verified SJR 0,763 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United States · Springer Science + Business...

workspace_premium Q1 — Oncology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Cancer Nanotechnology

Cancer Nanotechnology is a journal indexed in SJR in Oncology and Biomedical Engineering with an H index of 41. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1490 €. The scope of the journal is focused on nanostructures, nanoscale processes, cancer. It has an SJR impact factor of 0,763 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,763.

ISSN: 1868-6958

Publisher: Springer Science + Business Media

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,763 Q1

H-index 41

Acceptance rate pie_chart

36%

Source Acceptance_Rate

Time to publication hourglass_top

15 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.490 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,763

H-index

Docs (year)

Docs 3y

156

Total refs

3151

Cites 3y

788

Citable 3y

156

Cites/Doc 2y

4.76

Ref/Doc

55.28

Immediate OA

1490 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Aptamer-labeled PLGA nanoparticles for targeting cancer cells

Using water-soluble C60 fullerenes in anticancer therapy

Comb-like PEG-containing polymeric composition as low toxic drug nanocarrier

Clinical and pathological staging of the cancer at the nanoscale

Cisplatin-loaded hollow gold nanoparticles for laser-triggered release

Cisplatin-functionalized silica nanoparticles for cancer chemotherapy

Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells

Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles

Cancer Nanotechnology Startup Challenge: a new way to realize the fruits of innovation

C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes

Biotinylated magnetic nanoparticles for pretargeting: synthesis and characterization study

Biosynthesis of silver nanoparticles using the extract of Alternanthera sessilis - antiproliferative effect against prostate cancer cells

SHOW MORE ARTICLES

Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell

A comparison of the radiosensitisation ability of 22 different element metal oxide nanoparticles using clinical megavoltage X-rays

Application of nanotechnology to cancer radiotherapy

Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin

Antileukemic potential of PEGylated gold nanoparticle conjugated with protein toxin (NKCT1) isolated from Indian cobra (Naja kaouthia) venom

Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts

An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology

Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine

AGuIX nanoparticles as a promising platform for image-guided radiation therapy

Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment

Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles

A local effect model-based interpolation framework for experimental nanoparticle radiosensitisation data

FAQs

Cancer Nanotechnology has an SJR of 0,763 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 1490 EUR.

The acceptance rate recorded for Cancer Nanotechnology is 36%.

Cancer Nanotechnology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Nanotechnology?

What is the APC / publication cost?

What is the acceptance rate?